SPRIM Global Investments
Singaporesprim.com
Overview
SPRIM Global Investments is a privately held investment firm and the corporate venture capital arm of SPRIM, specializing in clinical-stage life sciences, pharma services, biotech, and medtech companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| ErVimmune | Jan 2026 | Series A | Co-investor |
| Lattice Medical | Oct 2025 | Series B | Co-investor |
| Vaxxas | Aug 2025 | Debt | Lead |
| Vaxxas | Aug 2025 | Series D | Lead |
| Azalea Vision | Apr 2025 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
